AF

Andrew Farnum

Chief Executive Officer

Variant Bio

Seattle, Washington


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Variant Bio
Industry
research
Employees
47.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
127739401.0
Latest Funding
Other

Technologies

Route 53 ElasticEmail Gmail Google Apps Microsoft Office 365 Vercel Mobile Friendly Vimeo Remote AI

Keywords

biotechnology research human genetics drug development biotech precision medicine treatment discovery therapeutic pipeline genomic research biomedical ethics life-saving therapies benefit sharing data generation genomic discovery deep phenotyping multi-omic data clinical trials genetic diversity community engagement collaborative research genomics molecular biology research partnerships data analytics bioinformatics genetic epidemiology ai in genomics clinical candidate drug discovery inflammatory diseases fibrotic diseases kidney diseases metabolic treatments community health initiatives patient outcomes molecular mechanisms disease targets ethics advisory board cultural sensitivity indigenous genetics transformative medicine research co-design health equity affordable medicines long-term benefits reciprocal relationships scientific innovation patient-centered research therapeutic candidates novel targets global partnerships data privacy health care health wellness & fitness hospital & health care information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans